全球蛋白質工程市場

到 2030 年，全球蛋白質工程市場將達到 78 億美元

全球蛋白質工程市場預計到 2023 年將達到 30 億美元，預計到 2030 年將達到 78 億美元，2023-2030 年分析期間複合年成長率為 14.5%。蛋白質工程儀器是本報告分析的細分市場之一，複合年成長率為 13.8%，預計到分析期結束時將達到 33 億美元。在分析期間，蛋白質工程試劑領域的複合年成長率預計為 14.7%。

美國市場預估為7.799億美元，中國預期複合年成長率為18.9%

預計 2023 年美國蛋白質工程市場規模將達 7.799 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達20億美元，2023-2030年分析期間複合年成長率為18.9%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 10.0% 和 12.2%。在歐洲，德國預計複合年成長率為 10.9%。

全球蛋白質工程市場—主要趨勢與促進因素總結

蛋白質工程如何形塑生物製藥的未來？

蛋白質工程透過開發具有更高功效、穩定性和目標特異性的客製化治療性蛋白質，正在徹底改變生物製藥。透過操縱蛋白質的結構，科學家可以創造單株抗體、酵素和其他具有針對治療特定疾病而最佳化特性的治療性蛋白質。例如，單株抗體在對抗癌症、自體免疫疾病和感染疾病方面已變得有價值，可提供減少脫靶效應並改善患者預後的標靶治療。同樣，酵素替代療法是蛋白質工程的另一個應用，對於高雪氏症和法布瑞氏症等遺傳性疾病的治療至關重要。蛋白質工程也對疫苗開發產生重大影響，工程蛋白質被用於對抗病毒威脅的疫苗中，以增強各種遞送形式的免疫反應和穩定性。在分子層面上客製化蛋白質的潛力使蛋白質工程成為精準醫學的基石，可以根據個體的基因組成客製化治療方法，提高治療成功率並減少副作用。隨著生物製藥公司不斷追求標靶治療，蛋白質工程處於最前沿，有助於將創新藥物和治療方法更快、更有效地推向市場。

合成生物學在蛋白質工程創新中扮演什麼角色？

合成生物學已成為蛋白質工程的強大工具，使研究人員能夠設計出滿足特定工業、環境或醫療需求的新型功能蛋白質。 CRISPR和TALEN等基因編輯技術的進步使得精確修改蛋白質結構、創造新功能和擴大蛋白質工程的應用變得更加容易。合成生物學也推動了工業過程中使用的永續酶的開發，用環保的生物催化劑取代了刺激性化學物質。例如，人工酵素現已廣泛應用於紡織、清潔劑和生質燃料產業，有助於降低能源消耗、減少廢棄物並提高效率。此外，透過結合計算模型和高通量篩檢，合成生物學使科學家能夠創造出在極端溫度和 pH 水平等惡劣條件下表現出更高穩定性和功能的蛋白質。以這種方式設計的蛋白質也被證明可用於環境淨化，旨在分解污染物或捕獲二氧化碳以幫助減輕環境破壞的蛋白質已被引入。合成生物學和蛋白質工程之間的協同效應使蛋白質在每個行業中都不可或缺，擴大了創新範圍，並使它們能夠被設計成各種可以想像的用途。

人工智慧和機器學習將如何改變蛋白質工程？

人工智慧和機器學習正在顯著加快設計和最佳化過程，從而改變蛋白質工程。傳統上，蛋白質工程一直是一個耗時的領域，需要無數次迭代才能實現所需的蛋白質特性。然而，隨著人工智慧演算法的引入，透過使用資料驅動的預測來模擬蛋白質行為，這種複雜性大大降低，使研究人員能夠以驚人的精度預測結構相互作用和修飾。基於蛋白質資料訓練的機器學習演算法使得預測蛋白質折疊、穩定性和功能成為可能，從而減少實驗試驗。公司和研究機構現在可以利用人工智慧主導的設計工具進行虛擬篩檢，在進行實體測試之前最佳化蛋白質結構。這在藥物發現中具有無價的價值，人工智慧有助於快速識別蛋白質標靶並加速治療方法的開發。此外，機器學習正在促進定向進化的使用，這是一種模仿自然選擇來進化具有特定特性的蛋白質的過程。透過將該技術與基於人工智慧的預測模型結合，科學家可以顯著提高蛋白質的效率和穩定性。人工智慧和機器學習在蛋白質工程中的融合，不僅提高了蛋白質修飾的準確性，而且使新型蛋白質的快速開發成為可能，徹底改變了該領域的科學發現方法。

蛋白質工程市場的成長受到多種因素的推動

蛋白質工程市場的成長受到多種因素的推動，包括技術進步、最終用途的擴大和不斷變化的消費者需求。 CRISPR 基因編輯、高通量篩檢和人工智慧驅動的預測模型等創新正在促進具有特定功能的蛋白質的設計，為藥物發現、診斷和工業應用開闢新途徑。製藥、農業、食品和飲料以及環境科學等最終用途產業擴大採用工程蛋白，為疾病治療、永續生產和環境清理提供客製化解決方案。例如，製藥業對生技藥品的需求不斷成長，推動了對能夠更有效地靶向疾病且副作用更少的工程蛋白質的需求，特別是在腫瘤學和免疫學等領域。此外，消費者對永續和環保產品的興趣正在推動用於日常產品的生物工程蛋白質的開發，從生物分解性的包裝到植物來源食品替代品。在環境科學中，旨在分解污染物或捕獲溫室氣體的蛋白質正被應用於減緩氣候變遷的努力。此外，個人化醫療的興起和精準診斷的推動正在加速工程蛋白在患者特異性治療方法和診斷中的使用，進一步擴大市場潛力。這些趨勢正在刺激蛋白質工程在多個方向上的發展，凸顯其在應對全球挑戰和消費者期望方面的變革性作用。

部分

產品（設備、試劑、軟體和服務）；最終用途（製藥和混合技術公司、合約研究機構、學術研究機構）；

受訪企業範例（18家知名企業）

• Abzena, Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Codexis, Inc.
• Creative Biolabs
• Danaher Corporation
• Enantis SRO
• GE Healthcare
• Genscript Biotech Corporation
• Innovagen AB
• Merck KGaA
• New England Biolabs, Inc.
• Perkinelmer, Inc.
• Phynexus, Inc.（A Part of Biotage）
• Promega Corporation
• Proteogenix
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Waters Corporation

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Protein Engineering Market to Reach US$7.8 Billion by 2030

The global market for Protein Engineering estimated at US$3.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Protein Engineering Instruments, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Protein Engineering Reagents segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$779.9 Million While China is Forecast to Grow at 18.9% CAGR

The Protein Engineering market in the U.S. is estimated at US$779.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 18.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 12.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Global Protein Engineering Market - Key Trends & Drivers Summarized

How Is Protein Engineering Shaping the Future of Biopharmaceuticals?

Protein engineering is revolutionizing biopharmaceuticals by enabling the development of tailored therapeutic proteins with enhanced effectiveness, stability, and target specificity. By manipulating protein structures, scientists can create monoclonal antibodies, enzymes, and other therapeutic proteins with optimized properties for treating specific diseases. Monoclonal antibodies, for instance, have become invaluable in the fight against cancer, autoimmune diseases, and infectious diseases, providing targeted therapies that reduce off-target effects and improve patient outcomes. Similarly, enzyme replacement therapies, another application of protein engineering, are essential for treating genetic disorders like Gaucher’s disease and Fabry disease. Protein engineering’s impact on vaccine development is also significant, with engineered proteins being used in vaccines against viral threats, enhancing immune response and stability in various delivery formats. The potential to customize proteins on a molecular level has positioned protein engineering as a cornerstone of precision medicine, where treatments are increasingly tailored to an individual's genetic makeup, increasing therapeutic success and reducing side effects. As biopharmaceutical companies continue to seek targeted therapies, protein engineering is at the forefront, helping bring innovative drugs and therapies to market faster and with improved efficacy.

What Role Does Synthetic Biology Play in Protein Engineering Innovation?

Synthetic biology has become a powerful tool within protein engineering, allowing researchers to design proteins with novel functionalities that meet specific industrial, environmental, and medical needs. Advances in gene-editing technologies like CRISPR and TALEN have made it easier to modify protein structures precisely, creating new capabilities and expanding protein engineering’s applications. Synthetic biology has also propelled the development of sustainable enzymes used in industrial processes, replacing harsh chemicals with environmentally friendly biocatalysts. For instance, engineered enzymes are now widely used in the textile, detergent, and biofuel industries, where they help reduce energy consumption, lower waste production, and improve efficiency. Moreover, by incorporating computational models and high-throughput screening, synthetic biology enables scientists to create proteins that exhibit enhanced stability and functionality under challenging conditions, such as extreme temperatures or pH levels. These engineered proteins are also proving valuable in environmental cleanup, where proteins designed to degrade pollutants or capture carbon dioxide are being deployed to mitigate environmental damage. The synergy between synthetic biology and protein engineering is expanding the possibilities for innovation, allowing proteins to be designed for virtually any application imaginable, making them indispensable across industries.

How Are AI and Machine Learning Transforming Protein Engineering?

AI and machine learning are transforming protein engineering by significantly speeding up the design and optimization processes. Traditionally, protein engineering was a time-intensive field, requiring countless iterations to achieve desired protein properties. However, the introduction of AI algorithms has dramatically reduced this complexity by using data-driven predictions to model protein behavior, enabling researchers to foresee structural interactions and modifications with remarkable accuracy. Machine learning algorithms trained on protein data have made it possible to predict protein folding, stability, and function, thus reducing experimental trial and error. Companies and research institutions are now able to utilize AI-driven design tools for virtual screening, optimizing protein structures before they are ever physically tested. This has proved invaluable in drug discovery, where AI helps identify protein targets quickly, accelerating the development of therapeutics. Additionally, machine learning is facilitating the use of directed evolution, a process that mimics natural selection to evolve proteins with specific characteristics. This technique, when combined with AI-based predictive modeling, allows scientists to enhance proteins’ efficiency and stability exponentially. The integration of AI and machine learning in protein engineering not only improves the accuracy of protein modifications but also enables the rapid development of novel proteins, revolutionizing the approach to scientific discovery in this field.

The Growth in the Protein Engineering Market Is Driven by Several Factors…

The growth in the protein engineering market is driven by several factors, including advances in technology, expanding end-use applications, and evolving consumer demands. Technological innovations such as CRISPR gene editing, high-throughput screening, and AI-powered predictive modeling are making it easier to design proteins with specific functions, opening new avenues in drug discovery, diagnostics, and industrial applications. End-use industries like pharmaceuticals, agriculture, food and beverage, and environmental science are increasingly adopting engineered proteins, as they offer tailored solutions for disease treatment, sustainable production, and environmental cleanup. For example, the growing demand for biologics in the pharmaceutical industry is driving the need for engineered proteins that can target diseases more effectively and with fewer side effects, particularly in fields like oncology and immunology. Additionally, consumer interest in sustainable and eco-friendly products is encouraging the development of bioengineered proteins for use in everyday products, from biodegradable packaging to plant-based food alternatives. In environmental science, proteins engineered to degrade pollutants or capture greenhouse gases are finding applications in climate change mitigation efforts. Furthermore, the rise of personalized medicine and the push for precision diagnostics are accelerating the use of engineered proteins in patient-specific therapies and diagnostics, further expanding the market’s potential. These converging trends underscore the transformative role of protein engineering in addressing both global challenges and consumer expectations, fueling its growth across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Protein Engineering market in terms of US$ Thousand by the following End-Use; Product; Technology, and Geographic Regions/Countries:

Segments:

Product (Instruments, Reagents, Software & Services); Technology (Rational Protein Design, Directed Evolution, Hybrid Approach); End-Use (Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 18 Featured) -

• Abzena, Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Codexis, Inc.
• Creative Biolabs
• Danaher Corporation
• Enantis S.R.O.
• GE Healthcare
• Genscript Biotech Corporation
• Innovagen AB
• Merck KGaA
• New England Biolabs, Inc.
• Perkinelmer, Inc.
• Phynexus, Inc. (A Part of Biotage)
• Promega Corporation
• Proteogenix
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Waters Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Protein Engineering - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Therapeutic Proteins in Biopharmaceuticals Drives Growth in Protein Engineering Solutions
  • Increased Focus on Precision Medicine Spurs Development of Customized and Targeted Protein Therapies
  • Advances in CRISPR and Gene Editing Technologies Expand Capabilities in Protein Engineering for Disease Treatment
  • Growth of Monoclonal Antibodies and Enzyme Replacement Therapies Elevates Market for Engineered Proteins
  • Increased Use of Protein Engineering in Vaccine Development Supports Market, Especially for Viral Disease Prevention
  • Rising Investment in Synthetic Biology Enhances Market for Engineered Proteins with Novel Functionalities
  • Expansion of Structural Biology and Computational Modeling Improves Accuracy and Efficiency in Protein Design
  • High Demand for Sustainable Industrial Enzymes Spurs Development of Engineered Proteins for Industrial Applications
  • Increased Focus on Biocatalysis in Pharmaceutical Manufacturing Drives Use of Custom Enzymes and Proteins
  • Growth in Agricultural Biotechnology Fuels Demand for Engineered Proteins in Crop Protection and Yield Enhancement
  • Advances in AI and Machine Learning Enhance Predictive Modeling for Protein Function and Stability
  • Rising Demand for Protein-Based Biosensors and Diagnostic Tools Expands Applications in Clinical and Environmental Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Rational Protein Design by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Rational Protein Design by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Directed Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Directed Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hybrid Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Hybrid Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Protein Engineering Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Protein Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• JAPAN
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• CHINA
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: China 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: China 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• EUROPE
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Protein Engineering by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• FRANCE
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: France 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: France 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: France 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• GERMANY
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Protein Engineering by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• INDIA
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 166: India 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 169: India 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 172: India 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Protein Engineering by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Protein Engineering by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Protein Engineering by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030
• AFRICA
  • Protein Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Protein Engineering by Technology - Rational Protein Design, Directed Evolution and Hybrid Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Protein Engineering by Technology - Percentage Breakdown of Value Sales for Rational Protein Design, Directed Evolution and Hybrid Approach for the Years 2014, 2024 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Protein Engineering by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Protein Engineering by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic Research Institutes for the Years 2014, 2024 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Protein Engineering by Product - Instruments, Reagents and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Protein Engineering by Product - Instruments, Reagents and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Protein Engineering by Product - Percentage Breakdown of Value Sales for Instruments, Reagents and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION